Hemanex, a medtech company specializing in blood processing, storage and transfusion, has raised $18 million in series B financing.
Hemanex has now raised $130 million. The funding comes as the company looks to expand into European commercial markets in 2023, according to a Nov. 7 Hemanex news release.
The company plans to keep the series B round open to investors for the next couple of weeks and is planning to launch a series C round in 2023.